| 000 | 01105 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250512080929.0 | ||
| 264 | 0 | _c19851115 | |
| 008 | 198511s 0 0 eng d | ||
| 022 | _a0022-1899 | ||
| 024 | 7 |
_a10.1093/infdis/152.5.1101 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHofflin, J M | |
| 245 | 0 | 0 |
_aDifluoromethylornithine and formycin B in toxoplasmosis. _h[electronic resource] |
| 260 |
_bThe Journal of infectious diseases _cNov 1985 |
||
| 300 |
_a1101 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xtherapeutic use |
| 650 | 0 | 4 | _aEflornithine |
| 650 | 0 | 4 |
_aFormycins _xtherapeutic use |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aOrnithine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aToxoplasmosis, Animal _xdrug therapy |
| 700 | 1 | _aGuptill, D R | |
| 700 | 1 | _aAraujo, F G | |
| 700 | 1 | _aRemington, J S | |
| 773 | 0 |
_tThe Journal of infectious diseases _gvol. 152 _gno. 5 _gp. 1101 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/infdis/152.5.1101 _zAvailable from publisher's website |
| 999 |
_c3936313 _d3936313 |
||